Sector consensus Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
06:00:00 25/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 11.72 USD | -1.43% |
|
-6.98% | -25.26% |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 28.5 | +143.17% | 6 | ||||||
| 688.17 | +20.73% | 23 | ||||||
| 277.94 | +1.06% | 18 | ||||||
| 432.8 | +20.23% | 28 | ||||||
| 253.92 | +27.05% | 22 | ||||||
| 267,786.94 | +50.95% | 22 | ||||||
| 581.83 | -6.25% | 12 | ||||||
| 72.24 | -7.05% | 14 | ||||||
| 272.16 | +35.3% | 20 | ||||||
| 68.56 | -16.64% | 18 | ||||||
| 289.29 | -1.75% | 14 | ||||||
| 185.25 | +6.53% | 16 | ||||||
| 3.908 | -22.88% | 7 | ||||||
| 70.73 | -2.54% | 11 | ||||||
| 50.57 | +16.26% | 11 | ||||||
| 138.64 | +19.71% | 22 | ||||||
| 46.27 | +3.83% | 15 | ||||||
| 174.69 | +27.2% | 13 | ||||||
| 135.01 | +65.75% | 7 | ||||||
| 638.68 | +126.65% | 19 | ||||||
| Average | 13,609.81 | +25.37% | 16 | ||||||
| Weighted average by Cap. | 21,407.04 | +17.84% | 19 |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
